Theriva Biologics Files 8-K on Financials

Ticker: TOVX · Form: 8-K · Filed: May 14, 2025 · CIK: 894158

Theriva Biologics, Inc. 8-K Filing Summary
FieldDetail
CompanyTheriva Biologics, Inc. (TOVX)
Form Type8-K
Filed DateMay 14, 2025
Risk Levellow
Sentimentneutral

Sentiment: neutral

Topics: financial-condition, results-of-operations, company-update

TL;DR

Theriva Biologics filed an 8-K on May 14, 2025, updating its financial and operational status.

AI Summary

On May 14, 2025, Theriva Biologics, Inc. (formerly Synthetic Biologics, Inc.) filed an 8-K report. The filing indicates a change in the company's financial condition and results of operations. Theriva Biologics, Inc. is incorporated in Nevada and its principal executive offices are located in Rockville, Maryland.

Why It Matters

This 8-K filing provides an update on Theriva Biologics' financial condition and operational results, which is crucial information for investors to assess the company's performance and future prospects.

Risk Assessment

Risk Level: low — This filing is a routine 8-K report detailing financial information and does not appear to contain significant adverse news.

Key Players & Entities

  • Theriva Biologics, Inc. (company) — Registrant
  • Synthetic Biologics, Inc. (company) — Former company name
  • May 14, 2025 (date) — Date of report
  • Nevada (jurisdiction) — State of incorporation
  • Rockville, Maryland (location) — Business address

FAQ

What is the primary purpose of this 8-K filing for Theriva Biologics, Inc.?

The primary purpose of this 8-K filing is to report on the company's Results of Operations and Financial Condition, as well as to include Financial Statements and Exhibits.

When was this 8-K report filed?

This 8-K report was filed on May 14, 2025.

What was Theriva Biologics, Inc. formerly known as?

Theriva Biologics, Inc. was formerly known as Synthetic Biologics, Inc.

In which state is Theriva Biologics, Inc. incorporated?

Theriva Biologics, Inc. is incorporated in Nevada.

What is the business address of Theriva Biologics, Inc.?

The business address of Theriva Biologics, Inc. is 9605 Medical Center Drive, Suite 270, Rockville, MD 20850.

Filing Details

This Form 8-K (Form 8-K) was filed with the SEC on May 14, 2025 regarding Theriva Biologics, Inc. (TOVX).

View full filing on EDGAR

View Full Filing

View this 8-K filing on SEC EDGAR

View on ReadTheFiling | About | Contact | Privacy | Terms

Data from SEC EDGAR. Not affiliated with the SEC. Not investment advice. © 2026 OpenDataHQ.